Coagulation factor XIII serves as protein disulfide isomerase

Thromb Haemost. 2009 May;101(5):840-4.

Abstract

Tissue transglutaminase was reported to act as protein disulfide isomerase (PDI). We studied whether plasma transglutaminase - coagulation factor XIII (FXIII) - has PDI activity as well. PDI activity was measured by determining the ability to renature reduced-denatured RNase (rdRNase). We found that FXIII can renature rdRNase, with efficiency comparable to commercial PDI. This PDI activity was inhibited by bacitracin. Like tissue transglutaminase, FXIII-mediated PDI activity is independent of its transglutaminase activity and is located on the A subunit. Surface-associated PDI has been previously shown to catalyse two distinct functions: transnitrosation with subsequent release of intracellular nitric oxide and disulfide bond rearrangement during platelet integrin ligation. Our results imply that FXIII-PDI activity may have a role in platelet function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies
  • Bacitracin / pharmacology
  • Cattle
  • Enzyme Inhibitors / pharmacology
  • Factor XIII / antagonists & inhibitors
  • Factor XIII / chemistry
  • Factor XIII / immunology
  • Factor XIII / metabolism*
  • Factor XIIIa / antagonists & inhibitors
  • Factor XIIIa / chemistry
  • Factor XIIIa / immunology
  • Factor XIIIa / metabolism*
  • Humans
  • Protein Disulfide-Isomerases / antagonists & inhibitors
  • Protein Disulfide-Isomerases / blood*
  • Protein Disulfide-Isomerases / chemistry
  • Protein Disulfide-Isomerases / immunology
  • Protein Renaturation
  • Protein Subunits
  • Ribonuclease, Pancreatic / metabolism*

Substances

  • Antibodies
  • Enzyme Inhibitors
  • Protein Subunits
  • Bacitracin
  • Factor XIII
  • Factor XIIIa
  • Ribonuclease, Pancreatic
  • Protein Disulfide-Isomerases